InsideArbtirage Potential Deal Alert: Echo Lake Capital offers to acquire Quince Therapeutics (QNCX) for $1.60 per share in cash

POTENTIAL DEAL DETAILS

Echo Lake Capital offers to acquire Quince Therapeutics (QNCX) for $1.60 per share in cash.

Update(s):

April 11, 2023: Quince Therapeutics, Inc. (QNCX) announced that its Board of Directors unanimously rejected the unsolicited proposal it received from Echo Lake Capital to acquire Quince for $1.60 per share in cash.

July 13, 2023: Echo Lake Capital increases its offer to acquire Quince Therapeutics. According to a July 13 letter discussed with the company’s board, Echo Lake Capital has increased its offer to acquire biotech business Quince Therapeutics (QNCX) from its previous offer of $1.60 per share to $1.80 per share.

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.